Latest News

NewMed Energy, Limited Partnership (TASE:NWMD) has reported FY 2025 third quarter revenue of US$238.9 million with basic EPS of US$0.11, setting the tone for investors focused on cash generation from its gas assets. Across recent periods, revenue has ranged from US$164 million to US$267.6 million per quarter, while basic EPS has moved between US$0.07 and US$0.13. This provides a clear read on how top line and per unit earnings have tracked through the last fiscal year. Against that backdrop,...

Why Westgold’s new financing and plant expansion matter for investors Westgold Resources (ASX:WGX) has paired a new A$600 million unsecured revolving credit facility with board approval to expand its Higginsville Processing Hub, moves that reshape its funding options and growth plans. See our latest analysis for Westgold Resources. The A$600 million unsecured facility and Higginsville expansion news landed against a mixed share price backdrop. The 1-day share price return of 4.87% contrasted...

Fanuc (TSE:6954) has drawn fresh attention after announcing a partnership with NVIDIA that uses NVIDIA's AI infrastructure so robots can train in digital twins, interpret voice commands, and auto generate Python code. See our latest analysis for Fanuc. Against this backdrop, Fanuc’s 1 year total shareholder return of 40.17% contrasts with a year to date share price return of a 4.31% decline and a 30 day share price return of a 6.41% decline, suggesting momentum has cooled after a strong...

Q3 2026 snapshot: Value Line (VALU) leans on margins as earnings trends soften Value Line (VALU) has just reported its Q3 2026 results, with recent quarters showing revenue around US$8.6 million and basic EPS between US$0.42 and US$0.69, while trailing twelve month EPS sits a little above US$2.25. Over the last six reported quarters, revenue has ranged from US$8.39 million to US$8.97 million and basic EPS has moved between US$0.42 and US$0.69, setting up a picture where high profitability...

Coya Therapeutics (COYA) has released its FY 2025 results, reporting fourth quarter revenue of US$4.0 million and a basic EPS loss of US$0.34, alongside trailing twelve month revenue of US$7.9 million and a basic EPS loss of US$1.27. The company’s revenue increased from US$0.00 million in the third quarter of 2024 to US$3.6 million in the third quarter of 2025, while quarterly basic EPS has ranged from a loss of US$0.44 in the first quarter of 2025 to a loss of US$0.13 in the third quarter of...

Zomedica (OTCPK:ZOMD.F) has reported its FY 2025 third quarter with total revenue of US$8.1 million and a basic EPS loss of US$0.006, alongside a net loss of US$6.1 million. Over recent quarters, revenue has moved from US$6.1 million in Q2 2024 to US$6.5 million in Q1 2025 and US$8.1 million in Q3 2025, while quarterly net losses have ranged from US$6.1 million to US$63.8 million and trailing twelve month revenue has reached US$29.5 million against a trailing net loss of US$84.5 million. For...

AGT Food and Ingredients FY 2025 Results Snapshot AGT Food and Ingredients (TSX:AGTF) has released a mixed FY 2025 update, reporting Q3 revenue of $654.2 million alongside a basic EPS loss of $0.62 and net income loss of $13.2 million, while trailing 12 month EPS is a loss of $0.46 on $3.2 billion of revenue. Over recent periods, the company’s quarterly revenue moved from $776.8 million in Q3 2024 to $1.0 billion in Q4 2024, then to $654.2 million in Q3 2025. EPS shifted from a $0.02 loss in...

Consolidated Water (CWCO) has put up another solid top line in FY 2025 so far, with Q3 revenue of about US$35.1 million and basic EPS of roughly US$0.35, while the latest trailing twelve months show revenue of about US$130.8 million and EPS of around US$1.09. Over recent periods the company has seen revenue move from roughly US$28.4 million in Q4 2024 to US$35.1 million in Q3 2025, with quarterly EPS shifting from about US$0.11 to US$0.35 over the same stretch. This sets up a story where...

In March 2026, Broadcom announced a suite of AI-focused networking and optical products, including its 3nm Taurus 400G/lane optical DSP and Tomahawk 6 switches, while also joining new industry groups such as the 400G Optical MSA and OCI MSA to define next‑generation, interoperable optical interfaces for large‑scale AI data centers. These launches and alliances show Broadcom moving beyond individual chips toward an integrated AI infrastructure stack, spanning compute, networking, optics, and...

Zymeworks (ZYME) is back in focus after announcing that one oral presentation and six abstracts from its proprietary antibody drug conjugate pipeline were accepted for the 2026 American Association for Cancer Research Annual Meeting. See our latest analysis for Zymeworks. The AACR update comes as the share price sits at US$24.04, with a 30 day share price return of 6.37%, a year to date share price return of 9.69%, and a 1 year total shareholder return of 94.81%. This suggests strong longer...

AXT (NasdaqGS:AXTI) reported material insider stock sales by its CEO and a director, alongside an update to revenue guidance. The company lowered revenue expectations after facing reduced export permits for indium phosphide from China. Management continues to emphasize expansion plans and a highly optimistic outlook despite these regulatory and operational challenges. These developments come as AXT trades at $44.36, with the stock showing very large gains of 2,464.2% over the past year and...

Apple (AAPL) continues to attract investor attention as a mega cap tech name, with the share price recently closing at US$254.23 and a 1 year total return of about 20%. See our latest analysis for Apple. Recent trading has been softer, with a 7 day share price return showing a 2.53% decline and a 90 day share price return showing a 6.48% decline, even as the 1 year total shareholder return is 20.05%. This suggests near term momentum has cooled while longer term performance remains...

MongoDB (NasdaqGM:MDB) has filed a $1.35b shelf registration for Class A Common Stock. The filing allows the company to issue shares over time to support corporate initiatives and potential ESOP related actions. The move introduces the possibility of a higher future share count, which may be relevant for existing and prospective shareholders. MongoDB enters this filing period with a share price of $272.27 and a mixed recent return profile. The stock is up 0.6% over the past week and 44.3%...

Equita Group (BIT:EQUI) has laid out its FY 2025 scorecard with third quarter revenue of €30.6 million and basic EPS of €0.13, putting hard numbers around how the year is shaping up after a share price of €5.31 coming into the release. The company has seen quarterly revenue move from €25.1 million in Q1 2025 to €32.4 million in Q2 and €30.6 million in Q3, while basic EPS tracked from €0.09 to €0.15 and then €0.13. This sets up a picture of earnings power that sits against a trailing net...

One Software Technologies (TASE:ONE) has just posted another set of detailed numbers for FY 2025, with third quarter revenue at ₪1.2b and basic EPS of ₪0.99 anchoring the latest update, while trailing 12 month revenue stands at about ₪4.5b and EPS at roughly ₪3.72. Over recent quarters the company has seen revenue move from ₪968.6m in Q2 2024 to ₪1.1b in Q2 2025 and then to ₪1.15b in Q3 2025, with basic EPS stepping from ₪0.74 to ₪0.93 and then to ₪0.99 over the same points in time. With...

StarragTornos Group (SWX:STGN) has just posted its FY 2025 first half results, with revenue of CHF218.2 million and a basic EPS loss of CHF1.66, while trailing twelve month figures show revenue of CHF457.3 million and a basic EPS loss of CHF0.69. Over recent reporting periods, revenue has moved from CHF254.9 million and EPS of CHF1.20 in 2024 H1 to CHF239.1 million and EPS of CHF0.97 in 2024 H2, before reaching the latest half-year levels. For investors, the focus is on how these changing...

The FDA approved an updated label for Krystal Biotech's Vyjuvek (beremagene geperpavec svdt) for epidermolysis bullosa. KB803 progressed as an emerging therapy candidate in Krystal Biotech's pipeline. These developments affect the treatment options available for epidermolysis bullosa and the outlook for NasdaqGS:KRYS. Krystal Biotech, listed on NasdaqGS:KRYS, focuses on gene therapies for rare skin conditions such as epidermolysis bullosa. With Vyjuvek already in the market and KB803 moving...

AngloGold Ashanti (NYSE:AU) completed its acquisition of Centamin in late 2024, bringing the Sukari mine into its portfolio. The Sukari mine produced 500,000 ounces of gold in 2025 and has been classified as a Tier 1 asset within the group. The company also completed its migration to a global domicile, with a primary NYSE listing and headquarters in London. For investors watching NYSE:AU, these changes follow a share price of $96.2 and a 12.4% gain year to date, with a very large return...

Napco Security Technologies (NSSC) is back in focus after an exceptional Q4, with revenue growth topping analyst estimates, supported by recurring service revenue and strong demand for its door locking products despite competitive and regulatory pressures. See our latest analysis for Napco Security Technologies. At a share price of $43.59, Napco’s short term share price performance has been relatively muted, with a 90 day share price return of 1.35%. Its 1 year total shareholder return of...

Blackstone (NYSE:BX) agreed to provide up to US$400 million in funding to Teva Pharmaceuticals to support development of a monoclonal antibody therapy for ulcerative colitis and Crohn’s disease. The Teva agreement is structured as a multi year commitment focused on late stage clinical work and potential commercialization of the therapy. Separately, Blackstone is pursuing a large acquisition in Australia’s pet food sector, targeting Real Pet Food Group as part of a broader push in consumer...

Why Clear Channel Outdoor Holdings Is On Investors’ Radar Clear Channel Outdoor Holdings (CCO) has drawn attention after recent performance data showed a 19% total return over the past 3 months and 110% over the past year, prompting fresh interest in its valuation. See our latest analysis for Clear Channel Outdoor Holdings. At a share price of $2.39, Clear Channel Outdoor Holdings has seen momentum build, with an 18.9% 90 day share price return alongside a 109.7% 1 year total shareholder...

If you are wondering whether BellRing Brands' share price reflects its true worth, this article breaks down what the current market price might be implying about the business. The stock most recently closed at US$18.51, with returns of 8.3% over the past 7 days, 3.6% over 30 days, but a 29.1% decline year to date and a 72.9% decline over the past year. Recent coverage has focused on BellRing Brands as investors react to the sharp 1 year share price decline and the longer term 3 year and 5...

The latest move in DNOW (DNOW) comes after its MRC Global acquisition ran into Oracle ERP rollout problems, missed financial expectations, weaker margins, and a shareholder lawsuit, all of which have weighed on recent trading. See our latest analysis for DNOW. That sharp 32.3% 1 month share price decline, alongside a 16.8% share price drop year to date, lines up closely with the Q4 miss, ERP setbacks, and subsequent lawsuit. At the same time, the 5 year total shareholder return of 11.42%...

lululemon athletica (NasdaqGS:LULU) has appointed Chip Bergh, former CEO of Levi Strauss & Co., to its Board of Directors. The appointment comes during an active period of founder-led boardroom pressure from Chip Wilson and an ongoing search for a new CEO. This board change adds an experienced apparel executive to the company as it works through governance questions and leadership succession. For investors watching NasdaqGS:LULU, this governance update arrives after a difficult share price...